SCHEMBL2631003

SCHEMBL2631003

CC(=O)C1C=C(c2nccnc2OC2CCN(C(=O)c3nc4ccccc4[nH]3)CC2)CCN1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2631027 0.92
SCHEMBL7705197 0.83 PDE10A (0.54) PDE10A
SCHEMBL2630770 0.82 PDE10A (0.55) PDE10A
SCHEMBL2630985 0.82 PDE10A (0.65) PDE10A
SCHEMBL2630800 0.81
SCHEMBL7710261 0.77 PDE10A (0.57) PDE10A
SCHEMBL2631116 0.76 PDE10A (0.68) PDE10A
SCHEMBL2631177 0.75
SCHEMBL2630991 0.75
SCHEMBL2630989 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2569302-A1 HETEROARYLOXYHETEROCYCLYL COMPOUNDS AS PDE10 INHIBITORS Amgen, Inc (US) 2013-03-20 EP disclosed
WO-2011143495-A1 HETEROARYLOXYHETEROCYCLYL COMPOUNDS AS PDE10 INHIBITORS AMGEN INC. (US) 2011-11-17 WO disclosed